Matches in Wikidata for { <http://www.wikidata.org/entity/Q94934635> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q94934635 description "clinical trial" @default.
- Q94934635 description "ensayo clínico" @default.
- Q94934635 description "ensayu clínicu" @default.
- Q94934635 description "klinisch onderzoek" @default.
- Q94934635 description "клінічне випробування" @default.
- Q94934635 description "կլինիկական փորձարկում" @default.
- Q94934635 description "临床试验" @default.
- Q94934635 name "ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19" @default.
- Q94934635 name "ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19" @default.
- Q94934635 type Item @default.
- Q94934635 label "ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19" @default.
- Q94934635 label "ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19" @default.
- Q94934635 prefLabel "ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19" @default.
- Q94934635 prefLabel "ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19" @default.
- Q94934635 P1050 Q94934635-CF40CAA6-A412-4E4D-A635-C46FBF3B308A @default.
- Q94934635 P1132 Q94934635-878B5A83-E212-4A0A-BB77-139E508B3BBA @default.
- Q94934635 P1476 Q94934635-80169BF3-B400-46D5-9349-836050B85D42 @default.
- Q94934635 P17 Q94934635-438FD225-322C-457F-9E44-57EF400A1B11 @default.
- Q94934635 P1813 Q94934635-EA9CCCE0-F107-4949-A395-3CE85B155452 @default.
- Q94934635 P2899 Q94934635-51A046A6-EB87-44C6-9720-92FFB5D483EE @default.
- Q94934635 P3098 Q94934635-E2FDF660-6CFF-4420-8655-1FF10B0E19E7 @default.
- Q94934635 P31 Q94934635-314B828E-CBB4-459D-A104-729CA0368F94 @default.
- Q94934635 P580 Q94934635-4FD8B29A-45DF-4BA0-8AA6-377D0BA111E7 @default.
- Q94934635 P582 Q94934635-CDDF6649-34AA-4A60-A4A0-56C5A537967B @default.
- Q94934635 P6099 Q94934635-97CD42CD-97F4-49CD-AA0D-D9AFF54BA325 @default.
- Q94934635 P6099 Q94934635-A87B9195-B8B8-48B7-9F15-E09546CD24A1 @default.
- Q94934635 P8005 Q94934635-C27D9272-8DD0-41FD-97C3-7B40F7F7AFC2 @default.
- Q94934635 P8363 Q94934635-40790AB9-C208-45BA-9731-C775DD6E0C39 @default.
- Q94934635 P1050 Q101991 @default.
- Q94934635 P1132 "+1034" @default.
- Q94934635 P1476 "A Phase 2/3, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and the Safety of ABX464 in Treating Inflammation and Preventing COVID-19 Associated Acute Respiratory Failure in Patients Aged ≥ 65 and Patients Aged ≥18 With at Least One Additional Risk Factor Who Are Infected With SARS-CoV-2." @default.
- Q94934635 P17 Q142 @default.
- Q94934635 P1813 "Mir-Age" @default.
- Q94934635 P2899 "+18" @default.
- Q94934635 P3098 "NCT04393038" @default.
- Q94934635 P31 Q30612 @default.
- Q94934635 P580 "2020-05-01T00:00:00Z" @default.
- Q94934635 P582 "2020-12-30T00:00:00Z" @default.
- Q94934635 P6099 Q42824440 @default.
- Q94934635 P6099 Q42824827 @default.
- Q94934635 P8005 Q76649708 @default.
- Q94934635 P8363 Q78089383 @default.